Situation: The Rural Health Unit (RHU) nurse extends services to population groups the program has reached poorly: key populations for HIV and an indigenous community in a geographically isolated and disadvantaged area (GIDA). The nurse reviews the groups that the HIV program classifies as key populations. Which group is a key population?

Key populations are groups at higher risk of HIV that often face stigma: men who have sex with men, transgender women, people who inject drugs, and people who sell sex. Other groups are offered testing for specific reasons, but they are not key populations.

Understanding key populations in HIV programming

The term key populations refers to specific groups that carry a disproportionately high burden of HIV infection and are therefore prioritized for targeted prevention, testing, and treatment services. These groups are defined not simply by any single risk event, but by sustained patterns of exposure combined with structural barriers—stigma, criminalization, and limited access to care—that make them epidemiologically and programmatically distinct.

The core key populations recognized in global and national HIV programs include men who have sex with men, transgender women, female sex workers, and people who inject drugs. Recent cohort and qualitative studies from India and Indonesia consistently operationalize key populations using these same categories ^[1][2][3]. In one retrospective cohort study, key populations were explicitly listed as female sex workers, men who have sex with men, transgender persons, and transsexual persons ^[1]. A separate qualitative study investigating pandemic experiences among HIV-positive key populations in Indonesia identified the four groups as men who have sex with men, transgender women, female sex workers, and people who use drugs ^[2][3].

Watch out! The defining feature is ongoing, population-level risk, not a one-time exposure. A health worker who sustains a needlestick, a pregnant woman at her first prenatal visit, or a partner of a tuberculosis client may each have a specific indication for HIV testing, but they do not constitute a key population because their risk is situational or event-based rather than tied to a sustained behavioral or structural vulnerability.

Group	Classification	Rationale for HIV testing
People who inject drugs	Key population	Sustained parenteral exposure through shared injection equipment; high background prevalence; stigma and legal barriers reduce service uptake
Health workers exposed to needlesticks	Not a key population	Occupational exposure event; requires post-exposure prophylaxis and testing, but risk is not population-level or ongoing
Pregnant women at first prenatal visit	Not a key population	Routine screening to prevent mother-to-child transmission; universal testing recommendation, not targeted key population programming
Partners of clients treated for tuberculosis	Not a key population	Contact investigation and integrated TB-HIV screening; risk is linked to a specific index case, not a defined population group

The distinction matters for nursing practice in a Rural Health Unit serving geographically isolated and disadvantaged areas. When the nurse extends services to an indigenous community and to key populations, the outreach strategy must differ. For key populations, services are designed around peer navigation, stigma reduction, and confidential or community-based delivery models because these groups often avoid facility-based care due to fear of discrimination or legal consequences ^[2]. For other groups such as pregnant women or TB contacts, testing is integrated into routine maternal and TB services without the same targeted outreach infrastructure.

Key point! A person who injects drugs belongs to a key population because injection drug use is a sustained behavior that carries ongoing HIV transmission risk and is associated with documented barriers to healthcare access. The other options describe individuals with a specific clinical indication for testing, but they are not classified as key populations in HIV program frameworks ^[1][2][3].